CD274 and sarcoma: Interestingly, we found a strong induction of PD-L1 expression on MeV-GFP-infected A673 sarcoma cells which builds up a rationale for a multimodal therapeutic approach combining virotherapy and NK cell-based therapy together with immune-checkpoint inhibition in the future.